IP Library Granted Patent US 10,007,759
Granted Patent B2
US 10,007,759 · App. 14/730,047 · Granted Jun 26, 2018

Infusion devices and methods

Inventors: Christopher V. Reggiardo (Castro Valley, CA); Namvar Kiaie (Danville, CA); James Thomson (Carollton, TX)
Assignee: Abbott Diabetes Care Inc.
G06F19/3406A61M5/14244A61M5/14276A61M5/1723G06F19/3468G06F21/30G06F21/44G16H40/63A61B5/14532A61M5/31525A61M5/31546A61M2205/276A61M2205/3561A61M2205/3569
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,007,759
App. No.
14/730,047
Granted
Jun 26, 2018
Kind
B2
Abstract

Medical devices having restrictive access, and methods thereof are provided.

Claims (8)

1. A method of controlling access to a medical system comprising at least one medical device and a data communication unit operable by each of a plurality of individuals including a healthcare professional, a caregiver and a user, the method comprising:

configuring a medical device with an access level hierarchy that enables the plurality of individuals to have different access level rights to set or modify parameters of the medical device, the access level hierarchy including at least a first, a second, and a third access level, wherein first access level rights enable a first individual having first access level rights to set, modify or lock prescriptive parameters and non-prescriptive parameters of the medical device, wherein second access level rights enable a second individual having second access level rights to set, modify or lock non-prescriptive parameters of the medical device that have not been locked by the first individual, wherein the second access level rights preclude the second individual from setting, modifying or locking prescriptive parameters of the medical device, wherein third access level rights enable a third individual having third access level rights to set, modify or lock non-prescriptive parameters of the medical device that have not been locked by the first or second individual, and wherein the third access level rights preclude the third individual from setting, modifying or locking prescriptive parameters of the medical device.

2. The method of claim 1 wherein the prescriptive parameters include one or more of a basal rate, an insulin ideal analyte range, an alert or alarm threshold, a medication type, a medication dose, a total daily medication dose, a drug sensitivity, a parameter associated with when to take mediation, a parameter associated with how to take medication, a parameter associated with when to treat a condition, a parameter associated with how to treat the condition, a reminder scheme, or any combination thereof.

3. The method of claim 1 wherein the non-prescriptive parameters include one or more of a non-prescriptive alarm value, a user menu access parameter, a data transfer and storage parameter, or any combination thereof.

4. The method of claim 1 wherein the medical device can be accessed using a web-based data management system.

5. The system of claim 4 wherein the web-based data management system can be accessed through a personal computer or laptop computer.

6. The system of claim 4 wherein the web-based data management system can be accessed through a cellular telephone.

7. The system of claim 1 wherein each access level is protected using one or more of a password, a token, or voice authentication.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2018
From: REGGIARDO, CHRISTOPHER V.; KIAIE, NAMVAR; THOMPSON, JAMES
To: ABBOTT DIABETES CARE INC.
Reel/Frame 046755/0816 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2018
From: REGGIARDO, CHRISTOPHER V.; KIAIE, NAMVAR; THOMSON, JAMES
To: ABBOTT DIABETES CARE, INC.
Reel/Frame 047051/0529 →
Continuity (3)
Continuation 14042629 · Sep 30, 2013
Continuation 11555207 · Oct 31, 2006
Related Publication 20150269340A1 · Sep 24, 2015